Evoke Pharma
EVOK
NASDAQ
IPO2013
about EVOK
Evoke Pharma develops pharmaceutical products primarily focused on urological conditions, including treatments for overactive bladder (OAB) through both oral medications and innovative intramuscular injections.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $10.70 | $10.79 | $10.66 | $7.15M | 3.95M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.62 | n/a | 7.30 | -41.55% | -41.87% | 0% |